期刊文献+

剩余风险——后低密度脂蛋白胆固醇时代到来? 被引量:2

Residual Risk——The Era of Post Low-density Lipoprotein Cholesterol?
下载PDF
导出
摘要 目前认为虽经过积极控制心血管疾病的危险因素,仍未能完全控制心血管疾病的发生发展,其主要原因在于心血管疾病"剩余风险"。血脂剩余风险主要包括三酰甘油升高,高密度脂蛋白胆固醇降低,或同时伴有载脂蛋白B和微小低密度脂蛋白升高;非脂类因素中,尿酸、高同型半胱氨酸血症及高纤维蛋白原血症等也在动脉粥样硬化等血管事件中起推动作用。此外、C反应蛋白、代谢综合征、激素、感染、内脂素等也通过不同途径影响冠心病的发生发展。 Although people were working hard to control the risk factors of cardiovascular disease,the occurrence and development of cardiovascular disease yet not able to be fully controlled.The main reason is the "residual risks"of cardiovascular disease.Residual risks including the increasing of triglycerides,high-density lipoprotein cholesterol,or apolipoprotein B in blood,sometimes accompanied by a slight increase in low-density lipoprotein.Non-lipid factors,such as uric acid,homocysteine and hyperfibrinogenemia are also other vascular events in the cardiovascular dieases.In addition,C-reactive protein,metabolic syndrome,hormones,infection and visfatin may affect the development of coronary heart disease through different channels.
出处 《心血管病学进展》 CAS 2013年第4期460-463,共4页 Advances in Cardiovascular Diseases
基金 上海申康医院发展中心慢性病综合防治项目(SHDC12012312)
关键词 剩余风险 高密度脂蛋白胆固醇 载脂蛋白 同型半胱氨酸 高纤维蛋白原血症 C反应蛋白 residual risk high-density lipoprotein cholesterol apolipoprotein homocysteine hyperfibrinogenemia C-reactive protein
  • 相关文献

参考文献1

二级参考文献2

共引文献8

同被引文献40

  • 1霍志成.血浆纤维蛋白原及血清脂蛋白(α)水平与老年人急性冠脉综合征的关系[J].广东医学,2007,28(1):132-133. 被引量:1
  • 21979年全国中西医结合治疗冠心病心绞痛及心律失常座谈会.冠心病心绞痛及心电图疗效评定标准[J].中国药事,1987,1(2):71-74.
  • 3Stone NJ. Reducing residual risk in secondary prevention of cardiovascular disease [ J ]. Circulation ,2012,125 ( 16 ) : 1958-1960.
  • 4Alagona P Jr. Beyond LDL cholesterol:the role of elevated triglyeerides and low HDL cholesterol in residual CVD risk remaining after statin therapy[J]. Am J Manag Care,2009,15(3 Suppl) :S65-S73.
  • 5Barter P, Gotto AM, LaRosa JC, et al. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular disease [ J ]. N Engl J Med, 2007,357 ( 13 ) : 1301-1310.
  • 6Chapman MJ, Ginsberg HN, Amarenco P, et al. The European Atherosclerosis Society Consensus Panel. Triglyceride-rich lipoproteins and high-density lipoprotein eholesterolin patients at high risk of cardiovascular disease : evidenceand guidance for management [ J ]. Eur Heart J,2011,32(11 ) :1345-1361.
  • 7Gibbons R J, Abrams J, Chatterjee K, et al. ACC/AHA2002 guideline update for management of patients with chronic stable angina-summary article:a report of the America College of Cardiology/American Heart Association Task Force on practice guidelines [ J ]. J Am Coil Cardiol, 2003,41 ( 1 ) : 159-168.
  • 8Tabas I, Williams KJ, Boren J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications [ J ]. Circulation,2007,116 ( 16 ) : 1832-1844.
  • 9Grundy SM. Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome[J].Am J Cardiol,1998,81 (4A) :18B-25B.
  • 10Miller M. Is hypertriglyceridaemia an independent risk factor for coronary heart disease? The epidemiologieal evidence[ J]. Eur Heart J, 1998,19( suppl H) :H18-H22.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部